Complementary distributions of amyloid-β and neprilysin in the brains of dogs and cats

Veterinary Pathology

Volumn 45, Issue 4, 2008, Pages 455-466

  Takeuchi, Y ^a   Uetsuka, K ^a   Murayama, M ^b   Kikuta, F ^c   Takashima, A ^b   Doi, K ^a   Nakayama, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c ST LUKE'S INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

Aging; Amyloid p; Brain; Cat; Neprilysin

Indexed keywords

CANIS FAMILIARIS;

AMYLOID BETA PROTEIN; MEMBRANE METALLOENDOPEPTIDASE;

AGE; ANIMAL; ANIMAL DISEASE; ARTICLE; BRAIN; BRAIN DISEASE; CAT; CAT DISEASE; DOG; DOG DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY;

AGE FACTORS; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; BRAIN DISEASES; CAT DISEASES; CATS; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NEPRILYSIN; STATISTICS, NONPARAMETRIC;

EID: 54749095986     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.45-4-455     Document Type: Article

References (53)

1. Abassi ZA, Tate JE, Golomb E, Keiser HR: Role of neutral endopeptidase in the metabolism of endo- thelin. Hypertension 20:89-95, 1992
2. Akiyama H, Kondo H, Ikeda K, Kato M, McGeer PL: Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition. Brain Res 902:277-281, 2001
3. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson- Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T: Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6:916-919, 2000
4. Barnes K, Doherty S, Turner AJ: Endopeptidase- 24.11 is the integral membrane peptidase initiating degradation of somatostatin in the hippocampus. J Neurochem 64:1826-1832, 1995
5. Barnes K, Turner AJ, Kenny AJ: Membrane localization of endopeptidase-24.11 and peptidyl dipeptidase A (angiotensin converting enzyme) in the pig brain: a study using subcellular fractionation and electron microscopic immunocytochemistry. J Neurochem 58:2088-2096, 1992
6. Beach TG, McGeer EG: The distribution of substance P in the primate basal ganglia: an immunohistochemical study of baboon and human brain. Neuroscience 13:29-52, 1984
7. Braak H, Braak E: Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm Suppl 53:127-140, 1998
8. Brellou G, Vlemmas I, Lekkas S, Papaioannou N: Immunohistochemical investigation of amyloid beta- protein (Abeta) in the brain of aged cats. Histol Histopathol 20:725-731, 2005
9. Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM: Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta- induced disorders. Neurobiol Aging 26:645-654, 2005
10. Cork LC, Powers RE, Selkoe DJ, Davies P, Geyer JJ, Price DL: Neurofibrillary tangles and senile plaques in aged bears. J Neuropathol Exp Neurol 47:629-641, 1988
11. Cummings BJ, Satou T, Head E, Milgram NW, Cole GM, Savage MJ, Podlisny MB, Selkoe DJ, Siman R, Greenberg BD, Cotman CW: Diffuse plaques contain C-terminal A beta 42 and not A beta 40: evidence from cats and dogs. Neurobiol Aging 17:653-659, 1996
12. Cummings BJ, Su JH, Cotman CW, White R, Russell MJ: Beta-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease. Neurobiol Aging 14:547-560, 1993
13. Czasch S, Paul S, Baumgartner W: A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain. Neurobiol Aging 27:293-305, 2006
14. Dickson DW: Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinico- pathological studies. Neurobiol Aging 18:S21-26, 1997
15. Erdos EG, Skidgel RA: Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 3:145-151, 1989
16. Fukami S, Watanabe K, Iwata N, Haraoka J, Lu B, Gerard NP, Gerard C, Fraser P, Westaway D, St George-Hyslop P, Saido TC: Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci Res 43:39-56, 2002
17. Haber SN, Nauta WJ: Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistry. Neuroscience 9:245-260, 1983
18. Head E, Barrett EG, Murphy MP, Das P, Nistor M, Sarsoza F, Glabe CC, Kayed R, Milton S, Vasilevko V, Milgram NW, Agadjanyan MG, Cribbs DH, Cotman CW: Immunization with fibrillar Abeta (142) in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain Abeta. Vaccine 24:2824-2834, 2006
19. Head E, McCleary R, Hahn FF, Milgram NW, Cotman CW: Region-specific age at onset of beta- amyloid in dogs. Neurobiol Aging 21:89-96, 2000
20. Head E, Moffat K, Das P, Sarsoza F, Poon WW, Landsberg G, Cotman CW, Murphy MP: Beta- amyloid deposition and tau phosphorylation in clinically characterized aged cats. Neurobiol Aging 26:749-763, 2005
21. Ishihara T, Gondo T, Takahashi M, Uchino F, Ikeda S, Allsop D, Imai K: Immunohistochemical and immunoelectron microscopical characterization of cerebrovascular and senile plaque amyloid in aged dogs' brains. Brain Res 548:196-205, 1991
22. Iwata N, Higuchi M, Saido TC: Metabolism of amyloid-beta peptide and Alzheimer's disease. Pharmacol Ther 108:129-148, 2005
23. Iwata N, Takaki Y, Fukami S, Tsubuki S, Saido TC: Region-specific reduction of A beta-degrading en- dopeptidase, neprilysin, in mouse hippocampus upon aging. J Neurosci Res 70:493-500, 2002
24. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC: Metabolic regulation of brain Abeta by neprilysin. Science 292:1550-1552, 2001
25. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-Aizawa Y, Saido TC: Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6:143-150, 2000
26. Kanemitsu H, Tomiyama T, Mori H: Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form. Neurosci Lett 350:113-116, 2003
27. Kenny AJ, Stephenson SL: Role of endopeptidase- 24.11 in the inactivation of atrial natriuretic peptide. FEBS Lett 232:1-8, 1988
28. Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, Higgs R, Liu F, Malkani S, Bales KR, Paul SM: Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 10:719-726, 2004
29. Matsas R, Kenny AJ, Turner AJ: An immunohisto- chemical study of endopeptidase-24.11 (''enkephali- nase'') in the pig nervous system. Neuroscience 18:991-1012, 1986
30. Mattson MP: Pathways towards and away from Alzheimer's disease. Nature 430:631-639, 2004
31. Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG: Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol 65:1012-1021, 2006
32. Mizutani T. Shinkei Byouri Shindan Atlas (Japanese) Bunkoudou, Tokyo, 1992
33. Morelli L, Llovera R, González SA, Affranchino JL, Prelli F, Frangione B, Ghiso J, Castano EM: Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme. J Biol Chem 278:23221-23226, 2003
34. Nakamura S, Nakayama H, Goto N, Ono-Ochikubo F, Sakakibara I, Yoshikawa Y: Histopathological studies on senile plaques and cerebral amyloid angiopathy in aged cynomolgus monkeys. Exp Anim 43:711-718, [in Japanese] 1995
35. Nakamura S, Nakayama H, Kiatipattanasakul W, Uetsuka K, Uchida K, Goto N: Senile plaques in very aged cats. Acta Neuropathol (Berl) 91:437-439, 1996
36. Nakamura S, Nakayama H, Uetsuka K, Sasaki N, Uchida K, Goto N: Senile plaques in an aged two- humped (Bactrian) camel (Camelus bactrianus). Acta Neuropathol (Berl) 90:415-418, 1995
37. Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO: Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9:448-452, 2003
38. Pham I, González W, el Amrani AI, Fournie-Zaluski MC, Philippe M, Laboulandine I, Roques BP, Michel JB: Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension. J Pharmacol Exp Ther 265:1339-1347,1993
39. Rofina JE, van Ederen AM, Toussaint MJ, Secreve M, van der Spek A, van der Meer I, Van Eerdenburg FJ, Gruys E: Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease. Brain Res 1069:216-226, 2006
40. Selkoe DJ, Bell DS, Podlisny MB, Price DL, Cork LC: Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 235:873-877, 1987
41. Shimada A, Kuwamura M, Awakura T, Umemura T, Yamane Y: Spongiform degeneration of the brain associated with uremia in an aged coyote (Canis latrans). Vet Pathol 31:484-487, 1994
42. Skidgel RA, Erdos EG: Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropep- tides: a brief history, the beginning and follow-ups to early studies. Peptides 25:521-525, 2004
43. Tapp PD, Siwak CT, Gao FQ, Chiou JY, Black SE, Head E, Muggenburg BA, Cotman CW, Milgram NW, Su MY: Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging. J Neurosci 24:8205-8213, 2004
44. Turner AJ: Neprilysin. In: Handbook of Proteolytic Enzymes, ed. Barrett AJ, Rawlings ND, and Woessner JF, vol. 1, 2nd ed., pp. 419-426. Academic Press, London, 2004
45. Uchida K, Nakayama H, Tateyama S, Goto N: Immunohistochemical analysis of constituents of senile plaques and cerebro-vascular amyloid in aged dogs. J Vet Med Sci 54:1023-1029, 1992
46. Uchida K, Tani Y, Uetsuka K, Nakayama H, Goto N: Immunohistochemical studies on canine cerebral amyloid angiopathy and senile plaques. J Vet Med Sci 54:659-667, 1992
47. Uchida K, Yoshino T, Yamaguchi R, Tateyama S, Kimoto Y, Nakayama H, Goto N: Senile plaques and other senile changes in the brain of an aged American black bear. Vet Pathol 32:412-414, 1995
48. Uchihara T, Kondo H, Akiyama H, Ikeda K: White matter amyloid in Alzheimer's disease brain. Acta Neuropathol (Berl) 90:51-56, 1995
49. Wang DS, Dickson DW, Malter JS: beta-Amyloid degradation and Alzheimer's disease. J Biomed Biotechnol 2006:58406, 2006
50. Wang DS, Iwata N, Hama E, Saido TC, Dickson DW: Oxidized neprilysin in aging and Alzheimer's disease brains. Biochem Biophys Res Commun 310:236-241, 2003
51. Wang DS, Lipton RB, Katz MJ, Davies P, Buschke H, Kuslansky G, Verghese J, Younkin SG, Eckman C, Dickson DW: Decreased neprilysin immuno- reactivity in Alzheimer disease, but not in pathological aging. J Neuropathol Exp Neurol 64:378-385, 2005
52. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J: Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9:453-457, 2003
53. Yasojima K, Akiyama H, McGeer EG, McGeer PL: Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci Lett 297:97-100, 2001